BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29401003)

  • 1. Prostate Cancer Screening and the Goldilocks Principle: How Much Is Just Right?
    Faiena I; Holden S; Cooperberg MR; Holden S; Soule HR; Simons JW; Morgan TM; Penson DF; Morgans AK; Hussain M
    J Clin Oncol; 2018 Apr; 36(10):937-941. PubMed ID: 29401003
    [No Abstract]   [Full Text] [Related]  

  • 2. Doing it right: how, not whether, to perform prostate-specific antigen screening.
    Martin NE
    Eur Urol; 2015 Sep; 68(3):361-2. PubMed ID: 25794459
    [No Abstract]   [Full Text] [Related]  

  • 3. Controversy of the prostate-specific antigen test era: should prostate cancer be detected and treated in all patients?
    Zhang N; Zhang XD
    Chin Med J (Engl); 2013; 126(15):2803-4. PubMed ID: 23924445
    [No Abstract]   [Full Text] [Related]  

  • 4. Summary statement on screening for prostate cancer in Europe.
    Heijnsdijk EAM; Bangma CH; Borràs JM; de Carvalho TM; Castells X; Eklund M; Espinàs JA; Graefen M; Grönberg H; Lansdorp-Vogelaar I; Leeuwen PJV; Nelen V; Recker F; Roobol MJ; Vandenbulcke P; de Koning HJ
    Int J Cancer; 2018 Feb; 142(4):741-746. PubMed ID: 29023685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer: Personalized risk - stratified screening or abandoning it altogether?
    Carlsson SV; Kattan MW
    Nat Rev Clin Oncol; 2016 Mar; 13(3):140-2. PubMed ID: 26831183
    [No Abstract]   [Full Text] [Related]  

  • 6. PSA cancer screening: a case for shared decision-making.
    Dasarathy J; Rajesh R
    J Fam Pract; 2020; 69(1):26;28;30;32;46. PubMed ID: 32017831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States.
    Nguyen DD; Trinh QD; Cole AP; Kilbridge KL; Mahal BA; Hayn M; Hansen M; Han PKJ; Sammon JD
    Cancer; 2021 Jan; 127(2):249-256. PubMed ID: 33165954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen (hK3) and human prostatic glandular kallikrein (hK2) in the detection of early stage human prostate cancer.
    Wilson MJ
    J Lab Clin Med; 1998 Apr; 131(4):298-9. PubMed ID: 9579381
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing localized prostate cancer in the era of prostate-specific antigen screening.
    Brooks JD
    Cancer; 2013 Nov; 119(22):3906-9. PubMed ID: 24006273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Prostate Cancer: Recommendation Statement.
    Am Fam Physician; 2018 Oct; 98(8):Online. PubMed ID: 30277733
    [No Abstract]   [Full Text] [Related]  

  • 11. Unorganized prostate-specific antigen-based screening for prostate cancer: more harm than benefit. When will we finally start to implement guidelines and risk assessment tools in clinical practice?
    Roobol MJ
    Eur Urol; 2015 Sep; 68(3):363-4. PubMed ID: 25769985
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for Prostate Cancer.
    Wolff T; Jadotte YJ
    Am Fam Physician; 2018 Oct; 98(8):537-538. PubMed ID: 30277736
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis of recommendations against prostate cancer screening with prostate specific antigen].
    Abascal Junquera JM; Fumadó Ciutat L; Francés Comalat A; Cecchini Rosell L
    Med Clin (Barc); 2016 Oct; 147(8):361-365. PubMed ID: 27085747
    [No Abstract]   [Full Text] [Related]  

  • 14. Divergent Responses to Mammography and Prostate-Specific Antigen Recommendations.
    Martinez KA; Rothberg MB
    Am J Prev Med; 2017 Oct; 53(4):533-536. PubMed ID: 28318901
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful separation between benign prostatic hyperplasia and prostate cancer by measurement of free and complexed PSA.
    Lilja H; Stenman UH
    Cancer Treat Res; 1996; 88():93-101. PubMed ID: 9239474
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate cancer screening can save lives but it is too early for a national programme, study finds.
    Sayburn A
    BMJ; 2014 Aug; 349():g5055. PubMed ID: 25102993
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate-specific antigen or human kallikrein 3? Recent developments.
    Diamandis EP
    Tumour Biol; 1998; 19(2):65-7; discussion 67-8. PubMed ID: 9486557
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving prostate-specific antigen screening.
    Strope SA; Andriole GL
    J Clin Oncol; 2010 May; 28(15):2491-2. PubMed ID: 20421536
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for prostate cancer.
    Croswell J; Shin YR
    Am Fam Physician; 2013 Feb; 87(4):283-4. PubMed ID: 23418805
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostate cancer: PSA velocity in prostate cancer screening--the debate continues.
    Borofsky MS; Makarov DV
    Nat Rev Urol; 2011 Jul; 8(8):413-4. PubMed ID: 21750502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.